Page last updated: 2024-08-16

ritanserin and sb 215505

ritanserin has been researched along with sb 215505 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdel-Raziq, MS; Gabr, MT1
Blackburn, TP; Holland, V; Kettle, A; Reavill, C; Riley, G1

Other Studies

2 other study(ies) available for ritanserin and sb 215505

ArticleYear
Pharmacophore-based tailoring of biphenyl amide derivatives as selective 5-hydroxytryptamine 2B receptor antagonists.
    MedChemComm, 2018, Jun-01, Volume: 9, Issue:6

    Topics:

2018
Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist.
    British journal of pharmacology, 1999, Volume: 126, Issue:3

    Topics: Animals; Binding, Competitive; Catalepsy; Cell Line; Dopamine Antagonists; Fluorobenzenes; Haloperidol; Humans; Indoles; Male; Piperidines; Quinolines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Antagonists

1999